Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329.SS)
CNY 30.47
(0.36%)
CNY 30.47
(0.36%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 2.52 Billion CNY | 5.86% |
| 2022 | 2.57 Billion CNY | 19.89% |
| 2021 | 2.14 Billion CNY | 8.28% |
| 2020 | 1.97 Billion CNY | -16.84% |
| 2019 | 2.38 Billion CNY | 10.24% |
| 2018 | 2.15 Billion CNY | 16.62% |
| 2017 | 1.85 Billion CNY | 9.72% |
| 2016 | 1.68 Billion CNY | 1.74% |
| 2015 | 1.65 Billion CNY | -5.94% |
| 2014 | 1.76 Billion CNY | 11.88% |
| 2013 | 1.57 Billion CNY | 5.12% |
| 2012 | 1.49 Billion CNY | 17.97% |
| 2011 | 1.27 Billion CNY | 16.16% |
| 2010 | 1.09 Billion CNY | 16.91% |
| 2009 | 936.03 Million CNY | 17.47% |
| 2008 | 796.84 Million CNY | -7.51% |
| 2007 | 861.54 Million CNY | -23.71% |
| 2006 | 1.12 Billion CNY | 7.7% |
| 2005 | 1.04 Billion CNY | 15.97% |
| 2004 | 904.16 Million CNY | 11.71% |
| 2003 | 809.36 Million CNY | 26.54% |
| 2002 | 639.6 Million CNY | 20.58% |
| 2001 | 530.45 Million CNY | 63.18% |
| 2000 | 325.07 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 696.94 Million CNY | -26.08% |
| 2024 Q2 | 625.42 Million CNY | -10.26% |
| 2024 Q3 | 617.81 Million CNY | -4.65% |
| 2023 Q1 | 696.64 Million CNY | -24.13% |
| 2023 Q4 | 942.89 Million CNY | 77.28% |
| 2023 FY | 2.72 Billion CNY | 5.86% |
| 2023 Q3 | 531.87 Million CNY | -12.84% |
| 2023 Q2 | 610.21 Million CNY | -12.41% |
| 2022 Q3 | 530.95 Million CNY | -5.82% |
| 2022 Q2 | 563.77 Million CNY | 1.15% |
| 2022 FY | 2.57 Billion CNY | 19.89% |
| 2022 Q1 | 557.36 Million CNY | 14.5% |
| 2022 Q4 | 918.22 Million CNY | 72.94% |
| 2021 Q3 | 524.66 Million CNY | -5.6% |
| 2021 Q4 | 486.77 Million CNY | -7.22% |
| 2021 FY | 2.14 Billion CNY | 8.28% |
| 2021 Q1 | 576.69 Million CNY | 31.59% |
| 2021 Q2 | 555.8 Million CNY | -3.62% |
| 2020 Q1 | 534.24 Million CNY | -2.54% |
| 2020 FY | 1.97 Billion CNY | -16.84% |
| 2020 Q2 | 545.94 Million CNY | 2.19% |
| 2020 Q3 | 461.52 Million CNY | -15.46% |
| 2020 Q4 | 438.25 Million CNY | -5.04% |
| 2019 Q3 | 582.85 Million CNY | -7.49% |
| 2019 Q1 | 619.8 Million CNY | 25.93% |
| 2019 Q2 | 630.02 Million CNY | 1.65% |
| 2019 FY | 2.38 Billion CNY | 10.24% |
| 2019 Q4 | 548.18 Million CNY | -5.95% |
| 2018 Q3 | 535.47 Million CNY | 0.35% |
| 2018 FY | 2.15 Billion CNY | 16.62% |
| 2018 Q4 | 492.16 Million CNY | -8.09% |
| 2018 Q1 | 598.37 Million CNY | 21.0% |
| 2018 Q2 | 533.6 Million CNY | -10.83% |
| 2017 Q4 | 494.53 Million CNY | 11.99% |
| 2017 Q3 | 441.59 Million CNY | -1.85% |
| 2017 Q2 | 449.91 Million CNY | -3.42% |
| 2017 FY | 1.85 Billion CNY | 9.72% |
| 2017 Q1 | 465.86 Million CNY | 3.25% |
| 2016 Q1 | 441.67 Million CNY | 21.6% |
| 2016 Q4 | 451.2 Million CNY | 6.41% |
| 2016 FY | 1.68 Billion CNY | 1.74% |
| 2016 Q3 | 424.03 Million CNY | 14.32% |
| 2016 Q2 | 370.93 Million CNY | -16.02% |
| 2015 FY | 1.65 Billion CNY | -5.94% |
| 2015 Q4 | 363.21 Million CNY | -9.93% |
| 2015 Q3 | 403.26 Million CNY | -8.39% |
| 2015 Q2 | 440.2 Million CNY | -2.66% |
| 2015 Q1 | 452.24 Million CNY | -6.82% |
| 2014 Q3 | 419.98 Million CNY | -6.95% |
| 2014 Q2 | 451.33 Million CNY | 10.86% |
| 2014 Q1 | 407.12 Million CNY | 0.04% |
| 2014 FY | 1.76 Billion CNY | 11.88% |
| 2014 Q4 | 485.33 Million CNY | 15.56% |
| 2013 Q3 | 356.79 Million CNY | -11.39% |
| 2013 Q4 | 406.94 Million CNY | 14.06% |
| 2013 Q1 | 410.09 Million CNY | 20.24% |
| 2013 Q2 | 402.63 Million CNY | -1.82% |
| 2013 FY | 1.57 Billion CNY | 5.12% |
| 2012 Q4 | 341.06 Million CNY | -4.02% |
| 2012 Q1 | 390.04 Million CNY | 14.78% |
| 2012 FY | 1.49 Billion CNY | 17.97% |
| 2012 Q2 | 413.21 Million CNY | 5.94% |
| 2012 Q3 | 355.33 Million CNY | -14.01% |
| 2011 Q3 | 306.67 Million CNY | 1.54% |
| 2011 FY | 1.27 Billion CNY | 16.16% |
| 2011 Q1 | 322.67 Million CNY | 6.36% |
| 2011 Q2 | 302.02 Million CNY | -6.4% |
| 2011 Q4 | 339.83 Million CNY | 10.81% |
| 2010 Q3 | 272.94 Million CNY | 8.99% |
| 2010 Q2 | 250.44 Million CNY | -6.39% |
| 2010 Q1 | 267.54 Million CNY | -1.21% |
| 2010 Q4 | 303.37 Million CNY | 11.15% |
| 2010 FY | 1.09 Billion CNY | 16.91% |
| 2009 Q1 | 228.22 Million CNY | 0.89% |
| 2009 FY | 936.03 Million CNY | 17.47% |
| 2009 Q4 | 270.82 Million CNY | 29.29% |
| 2009 Q3 | 209.46 Million CNY | -7.93% |
| 2009 Q2 | 227.51 Million CNY | -0.31% |
| 2008 Q2 | 198.84 Million CNY | 4.23% |
| 2008 Q3 | 181.01 Million CNY | -8.97% |
| 2008 Q4 | 226.22 Million CNY | 24.98% |
| 2008 Q1 | 190.77 Million CNY | -37.0% |
| 2008 FY | 796.84 Million CNY | -7.51% |
| 2007 Q3 | 172.77 Million CNY | -14.11% |
| 2007 Q4 | 302.8 Million CNY | 75.26% |
| 2007 FY | 861.54 Million CNY | -23.71% |
| 2007 Q1 | 184.81 Million CNY | -61.44% |
| 2007 Q2 | 201.15 Million CNY | 8.84% |
| 2006 Q3 | 171.84 Million CNY | -34.92% |
| 2006 Q1 | 214.16 Million CNY | -40.19% |
| 2006 Q4 | 479.26 Million CNY | 178.9% |
| 2006 FY | 1.12 Billion CNY | 7.7% |
| 2006 Q2 | 264.06 Million CNY | 23.3% |
| 2005 Q3 | 219.9 Million CNY | -14.26% |
| 2005 Q4 | 358.08 Million CNY | 62.84% |
| 2005 Q2 | 256.47 Million CNY | 19.79% |
| 2005 FY | 1.04 Billion CNY | 15.97% |
| 2005 Q1 | 214.09 Million CNY | -23.12% |
| 2004 Q4 | 278.48 Million CNY | 42.69% |
| 2004 Q2 | 230.23 Million CNY | 14.96% |
| 2004 FY | 904.16 Million CNY | 11.71% |
| 2004 Q1 | 200.27 Million CNY | -17.5% |
| 2004 Q3 | 195.16 Million CNY | -15.23% |
| 2003 FY | 809.36 Million CNY | 26.54% |
| 2003 Q4 | 242.76 Million CNY | 36.97% |
| 2003 Q1 | 158.9 Million CNY | -25.16% |
| 2003 Q3 | 177.24 Million CNY | -23.09% |
| 2003 Q2 | 230.44 Million CNY | 45.03% |
| 2002 Q4 | 212.32 Million CNY | 62.43% |
| 2002 Q2 | 163.96 Million CNY | 23.65% |
| 2002 Q1 | 132.6 Million CNY | 0.0% |
| 2002 FY | 639.6 Million CNY | 20.58% |
| 2002 Q3 | 130.71 Million CNY | -20.28% |
| 2001 FY | 530.45 Million CNY | 63.18% |
| 2000 FY | 325.07 Million CNY | 0.0% |